Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Journal of Clinical Medicine|January 8, 2023
Heparin-Induced Thrombocytopenia in Patients Undergoing Venoarterial Extracorporeal Membrane OxygenationEnzo Lüsebrink, Clemens Scherer, Leonhard Binzenhöfer, et al.Journal of Critical Care|May 8, 2022
Propofol versus midazolam sedation in patients with cardiogenic shock - an observational propensity-matched studyClemens Scherer, Jan Kleeberger, Antonia Kellnar, et al.Platelets|May 4, 2021
ADP-induced platelet reactivity and bleeding events in patients with acute myocardial infarction complicated by cardiogenic shockClemens Scherer, Enzo Lüsebrink, Danny Kupka, et al.Blood|December 24, 2023
Jak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talkWenli Liu, Joachim Pircher, Art Schuermans, et al.International Journal of Cardiology|April 21, 2022
Assessment of sex- and age-dependency of risk factors for intimal hyperplasia in heart transplant patients using the high resolution of optical coherence tomographyMadeleine Orban, Markus Dietl, Dominic Dischl, et al.Journal of Thrombosis and Haemostasis : JTH|March 6, 2026
Acetylsalicylic acid improves outcome after acute myocardial infarction by reduction of thromboinflammationCarolin Helten, Marcel Benkhoff, Philipp Mourikis, et al.Blood|April 29, 2022
Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administrationLeo Nicolai, Alexander Leunig, Kami Pekayvaz, et al.Nature Communications|April 20, 2018
Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammationJoachim Pircher, Thomas Czermak, Andreas Ehrlich, et al.International Journal of Cardiology|December 31, 2023
Heparin dosing in patients with Impella-supported cardiogenic shockChristophe Vandenbriele, René M'Pembele, Lisa Dannenberg, et al.JAMA Cardiology|March 31, 2021
Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 TrialKatharina Mayer, Ralph Hein-Rothweiler, Stefanie Schüpke, et al.Pageof 7